Position in LLY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$7,697,942
+$2,484,686 QoQ
Shares Held
6,418
+13.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.07%
of 13F equity value
Holder Rank
#1,408
of 4,604 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 78%
Shared 12%
None 10%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Gryphon Financial Partners LLC holds $43,846,091 across 10 Drug Manufacturers - General names. LLY ranks #2 (17.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
91,741 | $23,085,705 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
6,418 | $7,697,942 | |
| 3 | JNJ |
Johnson & Johnson
|
25,825 | $6,558,775 | |
| 4 | AMGN |
Amgen Inc
|
5,868 | $2,124,920 | |
| 5 | MRK |
Merck & Co., Inc.
|
16,044 | $2,061,654 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
6,540 | $826,263 | |
| 7 | GSK |
GSK plc
|
15,580 | $816,703 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,157 | $239,526 |
All Filings in LLY
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,697,942 | 6,418 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $5,213,256 | 5,668 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $5,591,560 | 5,203 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $3,798,977 | 4,979 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,313,000 | 4,250 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $3,491,120 | 4,227 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $2,947,496 | 3,818 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $3,850,294 | 4,346 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $3,627,856 | 4,007 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $2,888,564 | 3,713 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $1,354,706 | 2,324 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,045,791 | 1,947 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $928,579 | 1,980 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $682,031 | 1,986 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $560,832 | 1,533 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $481,789 | 1,490 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $454,245 | 1,401 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $337,343 | 1,178 | Shares | Other | 2022-05-05 | |
| 2021-12-31 | $299,421 | 1,084 | Shares | Other | 2022-02-01 | |
| 2021-09-30 | $240,522 | 1,041 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $227,453 | 991 | Shares | Other | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||